The complement-mediated lysis is inefficient when complement and target cells are homologous with regard to the species. In erythrocytes from patients suffering from paroxysmal nocturnal hemoglobinuria (PNH), the species restriction is lost: PNHerythrocytes (PNH-E) are susceptible to lysis by human complement. In human erythrocytes (huE) the species restriction is ascribed to an integral membrane protein, designated C8-binding protein (Cgbp). In the present study, we tested membranes of PNH-E type III for the presence of C8bp. A protein with C8-binding capacity could not be detected. C8bp, which was isolated from the membrane of huE, inhibited the lysis of PNH-E by C5b-9 as well as the C9 polymerization. Thus, addition of C8bp restored the species restriction in PNH-E. In conclusion, we propose that lack of C8bp might represent the defect in PNH-E type III membranes, which is responsible for their enhanced lytic susceptibility towards lysis by the late complement components.
Introduction
The complement-mediated lysis is inefficient when complement and target cells are from the same species (1, 2). The so-called "species restriction" is most probably due to membrane proteins interfering with the complement-membrane interactions at different steps of the complement cascade (3, 4) . In paroxysmal nocturnal hemoglobinuria (PNH),' a disease characterized by an abnormal sensitivity of the patient's erythrocytes (PNH-E) to complement-mediated lysis, the species restriction is apparently lost (5) (6) (7) (8) . In many studies, enhanced uptake ofC3 is noted (9, 10) . The enhanced C3 uptake is due to the lack ofa regulatory membrane protein, the so-called decay-accelerating factor (DAF) (I 1, 12). DAF inhibits the formation of the C3-convertases of either the classical or the alternative pathway of complement activation. Lack of DAF results in enhanced formation 1 . Abbreviations used in this paper: C8bp, C8-binding protein; DAF, decay-accelerating factor: huE, human erythrocytes; PNH, paroxysmal noctural hemoglobinuria; PNH-E, erythrocytes of patients suffering from PNH; VBS, veronal-buffered saline.
of C3-convertases, leading to an increased activation ofthe lytic complement complex (11) (12) (13) (14) . PNH-E of some patients (type III), however, are also more susceptible to lysis by the late complement components C5b-9. Therefore, in addition to the impaired regulation at the C3 step, the interaction ofthe late complement components with the membrane is affected in PNH-E type III (I15-19). Indeed, Hu and Nicholson-Weller (20) recently reported increases in binding of C9 to PNH-E type III in comparison with normal human erythrocytes (huE). Furthermore, a higher degree of C9 polymerization is seen, whereas insertion efficiency of C9 is similar in PNH-E and normal huE. The enhanced susceptibility of PNH-E to COb-9 appears to be species specific, i.e., lysis is only enhanced when PNH-E-C5b67 intermediates are lysed by human but not guinea pig C8 and C9 (21, 22) . Thus, the lack ofa factor restricting the lysis of huE seemed probable. Recently we identified a protein in huE membranes with the functional properties of a factor restricting the lysis by the late complement components C5b-9. This protein binds isolated human C8 and inhibits the lysis of erythrocytes-C5b67 intermediates by human C8 and C9, but not by C8 and C9 of another species (4). It is distinct from DAF (3, 4) and was tentatively designated C8-binding protein (C8bp). In the present study, we tested if erythrocyte membranes of patients suffering from PNH contained C8bp. The PNH-E that could be classified as type III, based on their susceptibility towards complement COb-9, did not contain a C8bp, which suggests that in PNH-E of type III lack of C8bp might be responsible for the enhanced lytic susceptibility of these cells.
Methods
Buffers. For the hemolytic assays, DGVB+ (50 ml veronal-buffered saline [VBS] mixed with 50 g dextrose and 0.1 g gelatin in 1,000 ml distilled water that contained MgSO4 and CaCl2 in final concentrations of 5.5 X 10-4 and 1.5 X 10' M, respectively) was used (23).
C9 were prepared according to the methods of Monahan et al. (27) (30) . Hemolytic activity was calculated as hit per cell (Z) (23) . As a further source of complement, a C8-deficient serum from a patient with a genetic C8 defect was used.
Acid activation ofnormal human serum or C8-deficient human serum.
To avoid activation of the early components, the serum containing 0.01 M EDTA was adjusted to pH 6.4 at 4VC with 0.5 M HCl, then neutralized with I M NaOH and used immediately (31).
Hemolytic assays. To generate C5b67 intermediates, 1 ml of huE was incubated with 2 ml C5b6 for 5 min at room temperature. Then 1 ml C7 was added. After incubation for 30 min at 30'C, the erythrocytes were washed and resuspended in I ml DGVB". 0.1 ml of these intermediates were lysed by addition of 0.1 ml C8 and 0.1 ml C9 and by incubation for 40 min at 37°C. 0.25-8 Mg of C5b6, I ug of C7 and [1] [2] [3] [4] Mg of C8 and C9 were used. When using whole or C8-deficient serum, I X 108/ml erythrocytes were incubated with 0.2 ml acidified serum diluted 1:5 in VBS that contained 0.01 M EDTA. To prepare erythrocytes-C5b67 intermediates, 0.1 ml erythrocytes were incubated with 0.2 ml acidified C8-deficient serum diluted 1:5 in VBS-EDTA for 30 min at 30°C. Erythrocytes were then centrifuged and washed.
Isolation ofC8 binding protein, C8bp. C8bp was isolated from huE membranes as described (4) . huE were washed, treated with papain, and then lyzed. The membranes were collected and extracted with phenol water. The proteins ofthe water phase were further purified by preparative isoelectric focusing. By this procedure, a protein of -65,000 D that yielded a single band in sodium dodecyl sulfate-polyacrylamide gel electrophoresis ($DS-PAGE) under reducing or nonreducing conditions was obtained.
Radiolabeling of C8bp. I mg C8bp was labeled with 12`J by using Bolton-Hunter reagent (250 ,Ci, New England Nuclear, Braunschweig, Federal Republic of Germany) according to the manufacturer's instruction. Free 125J was removed by gelfiltration on Sephadex G-25 and by dialysis. About 10% of the radioactivity was associated with the C8bp. Uptake ofC8bp by PNH-E. 109/ml PNH-E were incubated with 10 Mg 125J-C8bp for 30 min at 300C. The PNH-E were then washed repeatedly in DGVB++. Elution of C8bp was tested with DGVB++ substituted for 0.15 M up to 0.3 M NaCl. For trypsinization, 1 mg/ml trypsin (Serva, Heidelberg, Federal Republic of Germany) was incubated with the PNH-E for 30 min at 300C. After repeated washings, radioactivity that remained with the PNH-E as well as radioactive material released into the supernatant and the washing buffers were counted. To test association of 125J C8bp with the membranes, the PNH-E were lyzed as previously described.
Membranes were collected by centrifugation (Sorvall, DuPont Instrument, Bad Nauheim, FRG; 20,000 rpm for 20 min). Elution of 125J-C8bp was assayed with buffer of various ionic strength or trypsin as described above. For solubilization of the membranes, Triton X-100 or Nonidet (final concentration 0. 1I vol/vol) were used. Detection ofC8bp. C8bp was detected as described (4) . Erythrocyte membranes (equivalent to 200 ,ug protein) were separated by SDS-PAGE in a Laemmli system (4-17% gradient gel) (32) . After electrotransfer of proteins to nitrocellulose, which was performed with minor modification (33), the nitrocellulose strips were incubated with 5-10 yg purified C8 for 2 h at room temperature. By using anti-C8 (IgG fraction purchased from Miles Ames Div., Miles Laboratories Inc., Elkart, IN) and a peroxidase-labeled anti-IgG (Sigma Chemical Co., St. Louis, MO), binding of C8 could be demonstrated. Nitrocellulose strips that were incubated with buffer instead ofC8 and anti-C8, and anti-IgG, were used as control.
Preparation ofan antibody directed against C8bp. Rabbits were injected subcutaneously with a mixture of 0.5 mg purified C8bp and an equal volume of complete Freund's adjuvants. After 2 and 4 wk, the rabbits were boostered with C8bp emulgated with incomplete Freund's adjuvants. IgG was prepared from blood by ion-exchange chromatography.
Determination of C9 polymerization. Complement-lysed erythrocyte membranes were separated by SDS-PAGE under reducing conditions as described by Podack and Tschopp (34) . After blotting, C9 monomers and polymers could be demonstrated.
Results
Testfor C8-binding protein in the membrane ofPNH-E. Erythrocytes of five patients (Table I) (Fig. 2) . By scanning, the intensity of the bands was determined in PNH-E of the other patients. The data are summarized in Table I . In addition to the 65,000-D band, there was also a band of -32,000 D stained by anti-C8bp, which was missing in the PNH-E (Fig. 2) .
Effect ofpurified C8bp on the lysis ofPNH-E. The PNH-E (five different patients) were susceptible to lysis by acidified serum as well as by COb6, C7, and human C8 and C9. To test ifisolated C8bp would restore the homologous restriction in PNH-E, reincorporation of C8bp was assayed. The PNH-E (patient F.A.) were incubated with '25J-C8bp and bound -10% of the '25J-C8bp that was offered. Most of 125J-C8bp (-90%) remained associated with the erythrocytes or membranes of erythrocytes, Figure 3 . Inhibition of CMb-9-mediated lysis in PNH-E by C8bp.
PNH-E were preincubated with purified C8bp in different concentra- respectively, even after washing in buffers containing 0.3 M salt.
From the membranes, '25J could only be extracted with detergents; trypsinization had no effect. In PNH-E that carried purified C8bp, the lysis by acidified human serum as well as by C5b-9 was inhibited (data shown for patients F.A. and A.A., Figs. 3 and 4). PNH-E bound up to 10' molecules of C8bp per erythrocyte. -1,000 molecules, however, were sufficient to yield a 50% inhibition of lysis.
Effect ofC8bp on the C9 polymerization. Recent data by Hu and Nicholson-Weller showed that in PNH-E, in contrast to huE, C9 polymerization was seen after treatment with whole human complement. Therefore, we tested if C8bp would affect the C9 polymerization. To yield a high number of C7 sites, in these experiments the erythrocytes were loaded with acid-activated C8-deficient human serum. The washed erythrocytes were then incubated either with C8bp and excess ofpartially purified C8 plus C9 or with C8 and C9 alone. After incubation for 60 min at 370C, the nonlysed erythrocytes were removed, and the membranes were collected and separated by SDS-PAGE. Using PNH-E, a band that could be identified by immunoblot as poly-C9 was seen on top of the gel (Fig. 5) . Using normal huE, the poly-C9 band was missing (Fig. 5) . When, however, the PNH-E-Cl-7 intermediates were incubated with C8bp and excess of human C8 and C9, the formation of poly-C9 was inhibited (data shown for patient A.A., Fig. 5 ).
Discussion
In 1937, Ham described that PNH-E could be lyzed by acidactivated serum (1) . Acidification of human serum (i.e., shift of serum pH to 6.4) causes, independent of the C3-convertases, the generation ofa C56 complex, termed C(56)a. C(56)' together with C7, C8, and C9 cause lysis ofchicken erythrocytes or PNH-E (22, 31).
Enhanced lytic susceptibility of PNH-E by human complement was also seen; it was activated by antigen-antibody complexes or by the alternative pathway (6) (7) (8) (9) . While investigating the reason for the enhanced lytic susceptibility of PNH-E by human complement, it was noted that PNH-E bind much higher amounts of C3 than normal huE (9, 10) . Enhanced C3 uptake was due to the lack of an intrinsic membrane protein, DAF, which regulates the formation and decay of the C3-convertases (12) (13) (14) . Enhanced uptake of C3, however, cannot be the only reason for the abnormal sensitivity of PNH-E, because in some patients enhanced susceptibility towards lysis by the late complement components C5b-9 (16-21) or C(56)a-9 (22) isalso seen (i.e., in the total absence of C3). The reason for the enhanced susceptibility is still under investigation; meanwhile, enhanced binding ofthe components ofthe attack phase has been suggested (35) . Other authors, however, reported that in absence of C3 (i.e., using isolated C5b6, C7, C8 and C9) the uptake and incorporation ofthe components into the membrane-attack complex is equal to that ofnormal erythrocytes (36) . When, however, whole serum was used, enhanced C9 uptake was seen as well as enhanced C9 polymerization (20) . The enhanced lysis was only observed when human and not guinea pig C8 and C9 were used (21, 22) . Therefore, it was reasonable to postulate that in PNH-E type III the factor restricting the lysis in the homologous system was missing. A membrane protein with properties of a speciesrestricting factor was described recently (4) .
In the present study we tested, if this C8bp was present in PNH-E. In the purified PNH-E membranes, C8bp was missing when tested by binding of isolated C8 or by antibody. In the patients the amount of C8bp was greatly reduced. Being aware of the problems of quantitating from an immunoblot, a rough correlation between the amount of C8bp and the lytic susceptibility was obvious. Whether the erythrocytes in PNH expressed only low amounts of C8bp, or there were two populations of erythrocytes, a normal one expressing C8bp and an afflicted one, which did not have C8bp, cannot be decided yet. The fact, however, that the purified PNH-E did not contain measurable amounts of C8bp points to the possibility ofdifferent erythrocyte populations.
In addition to the 65,000-D band, a further band of -32,000 D stained by anti-C8bp was seen, which was missing in the PNH-E. Whether this band represents another form ofC8bp or a split product is not yet clear; however, it most likely indicates a form ofC8bp, probably identical with inhibitory protein described by Zalman and Muller-Eberhard (36) .
Isolated C8bp was reincorporated into membranes. After lysis of the erythrocytes it remained associated with the membranes. C8bp cannot be eluted by buffers in high-ionic strength, but it can by nonionic detergents or SDS. Addition of C8bp to PNH-E restored the homologous species restriction; purified C8bp inhibited the lysis of PNH-E or PNH-E-C5b-7 intermediates by C5b-9 or human C8 and C9, respectively. Furthermore, C8bp inhibited the C9 polymerization that was seen after lysis by human complement in the membrane of PNH-E, but not in normal huE.
How C8bp in normal erythrocytes restricts the lysis is not yet known. From our recent data (4) and the comparison of lysis of huE, PNH-E, and PNH-E coated with C8bp we like to propose the following reaction mechanism: in a heterologous system or a model lipid membrane, C8 (bound to the C5b-7 complex) binds C9 and is thought to catalyze C9 polymerization (33) . Even though it is doubtful if C9 polymerization is a prerequisite for lysis, it still serves as a suitable indicator ofthe C8-C9 interaction. Most probably the C8 a-chain is involved in C9 polymerization (37), whereas binding to the C5b67 complex is mediated by the (i-chain. The C8 a-y-subunit also binds the C8bp (38) , which is in accordance with the fact that C8bp does not interfere with the binding ofC8 to C5b-7; instead, it interferes with one of the sequential reactions (i.e., inhibition of C9 polymerization) and probably also with C5b-9 insertion. Since the C8bp function was missing, uptake of C5b-8 would not be affected; however, the C8-C9 interaction would be modulated: enhanced uptake ofC9 might occur as well as C9 polymerization and probably also enhanced C5b-9 insertion. In this respect, PNH-E behaved exactly like cells with a C8bp function missing: normal uptake of C5b-8 (18, 20) is seen, but enhanced uptake of C9 and C9 polymerization was observed as well as enhanced lysis. Considering that a C8bp function could not be demonstrated, we propose that a protein with C8-binding capacity was the species-restricting inhibitor in the lysis of huE, and that a lack of this inhibitor-as it is seen in patients suffering from PNH type III-results in enhanced susceptibility towards lysis by the late complement components.
